Rose Radin

United States Food and Drug Administration

Poster(s):

• (B-129) Attention-Deficit/Hyperactivity Disorder Medication Utilization Among U.S. Adults Ages 18-64 Years with Commercial Insurance or Medicare: Implications for Design of Inferential Safety Studies
  Monday, August 25, 2025

  11:30 AM - 1:00 PM ET

• (C-247) Cannabis-Related Healthcare Encounters among Commercially Insured Adults Aged 18-64 Years Contributing Data to the US Food And Drug Administration’s Sentinel, 2017-2022
  Tuesday, August 26, 2025

  12:00 PM - 1:30 PM ET

• (A-221) Self-Reported Use of Non-FDA Approved Cannabinoid Products among Hospitalized Patients in a Large US Hospital Network
  Sunday, August 24, 2025

  12:00 PM - 1:30 PM ET